Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

SHE:002198 Revenue

Guangdong Jiaying Pharmaceutical had revenue of 122.92M CNY in the quarter ending March 31, 2026, with 1.06% growth. This brings the company's revenue in the last twelve months to 385.04M, down -4.55% year-over-year. In the year 2025, Guangdong Jiaying Pharmaceutical had annual revenue of 383.75M with 2.02% growth.

• Revenue (ttm): 385.04M
• Revenue Growth: -4.55%
• P/S Ratio: 7.32
• Revenue / Employee: 648.21K
• Employees: 594
• Market Cap: 2.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	383.75M	7.58M	2.02%
Dec 31, 2024	376.17M	-157.07M	-29.46%
Dec 31, 2023	533.23M	-125.96M	-19.11%
Jan 1, 2023	659.20M	84.48M	14.70%
Jan 1, 2022	574.71M	29.98M	5.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error